3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colonic Neoplasms
1
Interventions
Oxaliplatin
14
Cetuximab
11
Leucovorin
9
Fluorouracil
9
Magnetic Resonance Spectroscopy
8
Nivolumab
7
pembrolizumab
6
Capecitabine
6
encorafenib
5
Irinotecan
5
Bevacizumab
5
dehydroftorafur
4
Specimen Handling
4
adagrasib
3
Immunoglobulin G
3
Disulfides
3
Biopsy
3
selpercatinib
2
durvalumab
2
cemiplimab
2
X-Rays
2
Watchful Waiting
2
Standard of Care
2
Radiotherapy
2
Panitumumab
2
Observation
2
Ipilimumab
2
Injections
2
Gemcitabine
2
Folfox protocol
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Colonic Neoplasms
×
eicosapentaenoic acid ethyl ester
×
Clear all
NCT03428477
2025-04-18
EMT2
University of Leeds
Phase 3
Active not recruiting
418 enrolled